Global Market Access

The European Medicines Agency (EMA) conducted its fourth system demonstration of 2025, highlighting its consistent advancement in the digital landscape to better serve its...

The significance of primary healthcare (PHC) in managing diabetes becomes an important area of exploration as China's healthcare system grapples with efficiency challenges. Amid...

Austria is spearheading an innovative approach to healthcare with the development of a programme theory for social prescribing (SP) in primary care environments. Implemented...

Collegium Pharmaceutical is riding a wave of robust growth, closing the third quarter of 2025 with exceptional financial results. The company revealed a striking...

Amidst dynamic and challenging global landscapes, Ambu A/S has reported formidable financial outcomes for FY 2024/25. With geopolitical tensions swirling and macroeconomic factors at...

In the rapidly evolving orthopedic industry, Anika Therapeutics has solidified its presence with impressive growth markers in its latest report. The company doesn’t just...

Australia's alfalfa sprout consumers face a health alert following a national recall initiated by Parilla Fresh due to possible Salmonella contamination. The recall comes...

A recent study uncovers a critical public health concern among US Veterans: alarmingly low rates of respiratory syncytial virus (RSV) vaccine uptake. This data,...

October witnessed remarkable strides in health innovation across Catalonia, characterized by cutting-edge research breakthroughs, strategic investments, and significant technological advancements. This month showcased a...

A subtle but powerful regulatory move by the U.S. FDA may redefine how global pharmaceutical markets approach access, localization, and regulatory strategy. Earlier this...

A recent agreement between pharmaceutical giant GSK and biotech innovator Syndivia has unveiled a promising new chapter in prostate cancer treatment. Cementing GSK's strategic...

The realm of international medicines regulation witnessed a pivotal moment at the recent ICMRA Summit 2025 held in Amsterdam. With the conclusion of Emer...

Global pharmaceutical giant F. Hoffmann-La Roche Ltd. has reported its financial performance for the third quarter of 2025, showcasing a growth trajectory amid evolving...

Amid growing concerns about cardiovascular diseases, Merck propels its research momentum at the American Heart Association (AHA) Scientific Sessions 2025, delivering pivotal insights into...

The Molecule Independent Device Bridging Approach (MIDBA) with YpsoMate represents a significant milestone in drug delivery innovations. Unlike traditional methodologies, MIDBA opts for an...